SINGAPORE, Dec. 7, 2025 /PRNewswire/ -- AI/ML health-tech startup Respiree has received approval from the Health Sciences Authority (HSA) for its 1Bio™AI-Acute toolbox as a Class B ...

Early safety from a phase 1, multicenter, open-label clinical trial of talimogene laherparepvec (T-VEC) injected into liver tumors.

(HealthDay)—For deteriorating adult patients in the emergency department, no family presence and physical family presence result in predominantly negative clinician-family-patient interactions, while ...

Early neurological deterioration (END) represents a rapid worsening of neurological function within hours to days of acute ischaemic stroke onset. Affecting up to 15 per cent of patients undergoing ...

Acute-on-chronic liver failure (ACLF) is a life-threatening condition characterized by acute deterioration of liver function in patients with pre-existing chronic liver disease. It is often ...

PHOENIX, AZ—IV tirofiban lessens early neurological deterioration when given within 24 hours of symptom onset in patients with an acute noncardioembolic ischemic stroke who aren’t treated with IV ...

Intravenous (IV) administration of the antiplatelet agent tirofiban for 72 hours was associated with a reduction in early neurologic deterioration compared with oral aspirin therapy in patients with ...

Approximately 1.5 million people in the UK have a learning disability and it is estimated that around 1% of the population has an autism spectrum condition. People with learning disabilities and ...

The 1Bio™AI-Acute system uses only bedside-recorded vital signs—pulse rate, respiratory rate, oxygen saturation, and systolic blood pressure—to generate a probability score that assists clinicians in ...